Master Thesis on Antiviral siRNA Therapy

We are seeking a motivated Master's student with a life science background to join our research group at the
LMU clinic. We have developed an RNA interference-based antiviral therapy that targets and destroys the
genome of SARS-CoV2 (NAR 2022; https://doi.org/10.1093/nar/gkab1248). Your project will focus on further
improving this therapeutic approach and expanding its effectiveness to the entire Orthocoronavirinae subfamily,
making it crucial for pandemic preparedness.

Our Offer:
• Engage in a highly relevant and exciting research project at the forefront of antiviral research.
• Work in an interdisciplinary team of young researchers.
• Access state-of-the-art technical equipment, infrastructure, and a stimulating scientific environment.

Techniques you will be using:
• Basic cell culture methods
• Dual luciferase reporter assay system
• Various virology methods
• Real-Time qPCR

Qualifications:
• BSc in Biology, Biochemistry, or a related field.
• A deep passion, dedication, and curiosity for research.
• Strong team and communication skills.
• Extensive wet lab experience is welcome. Experience in virology is beneficial but not required.

We strive for an inclusive, open and diverse work environment and welcome applications from people of any
ethnicity, religion, gender or age. Severely disabled persons are given preference in the case of equal suitability.
If interested, please send your letter of motivation, a copy of your academic transcripts and at least one email
contact for references from your previous supervisor(s) to: julian.vogler@med.uni-muenchen.de